U.S. Gas Utilities Stock News

Copart (CPRT) is back in focus after scheduling its second quarter fiscal 2026 earnings release for February 19 and recently securing a new US$1.25b unsecured revolving credit facility. See our latest analysis for Copart. The upcoming earnings release and fresh US$1.25b credit facility come after a softer period for the shares, with a 1 year total shareholder return decline of 38.63% and a 5 year total shareholder return of 23.67%. This suggests that shorter term momentum has faded while...

Molina Healthcare recently reported a fourth-quarter 2025 loss and sharply weaker 2026 profit guidance, citing elevated medical costs, retroactive Medicaid adjustments, and plans to exit its underperforming Medicare Advantage Part D product in 2027. Alongside a US$93 million non-cash impairment and a covenant amendment that temporarily relaxes its minimum interest coverage ratio, these developments have raised fresh questions about the resilience of Molina’s business model under sustained...

In early February 2026, GitLab Inc. hosted its GitLab Transcend virtual event and related calls to showcase how its Intelligent Orchestration and agentic AI capabilities can automate software delivery while preserving security, compliance, and governance. The company also launched initiatives such as an AI agent hackathon and a forthcoming assessment program, underscoring a broader shift toward AI-led workflows and away from traditional seat-based models that many analysts now see as...

NRG Energy (NRG) is back on watch for investors after recent share price moves, with the stock closing at $161.80 as the company continues operating across power generation, retail energy and home services. See our latest analysis for NRG Energy. The latest move to $161.80 extends a 7 day share price return of 12.02% and a 30 day share price return of 7.44%. However, year to date the share price return is slightly negative, while the 1 year total shareholder return of 54.17% and very large 3...

Fluor (NYSE:FLR) has been selected as the lead EPC contractor for Centrus Energy's expansion of U.S. uranium enrichment capacity. The multi year project is aimed at supporting commercial and national security needs for enriched uranium in the United States. The contract reinforces Fluor's role in large scale nuclear and energy infrastructure at a time of growing focus on domestic fuel capabilities. For investors tracking NYSE:FLR, this new EPC role arrives with the stock at $45.67 and multi...

AGNC Investment (AGNC) has reaffirmed its monthly dividend, declaring a US$0.12 per share cash payout for February 2026. This decision puts income reliability and dividend sustainability back in the spotlight for investors. See our latest analysis for AGNC Investment. AGNC’s share price sits at US$11.38 after a modest 90 day share price return of 12.12%, while its 1 year total shareholder return of 27.58% highlights how the dividend has shaped overall results over time. If this dividend news...

Confluent (CFLT) just wrapped up FY 2025 with Q4 revenue of US$314.8 million and a basic EPS loss of US$0.23, while trailing twelve month revenue sat at about US$1.17 billion against a full year basic EPS loss of US$0.86. Over recent quarters, the company has seen revenue move from US$261.2 million in Q4 2024 to US$314.8 million in Q4 2025, with quarterly basic EPS losses ranging between US$0.19 and US$0.27. The latest print keeps the spotlight firmly on how quickly revenue growth can offset...

If you are wondering whether PennyMac Mortgage Investment Trust is offering good value at its recent share price, you are not alone. This article is designed to help you make sense of that question. The stock most recently closed at US$12.49, with returns of 2.0% over the past week, a 5.2% decline over the past month, a 1.3% decline year to date, and a 3.4% return over the last year, alongside cumulative returns of 26.2% over three years and 22.1% over five years. Recent coverage has focused...

Sarepta Therapeutics (NasdaqGS:SRPT) received Medsafe approval in New Zealand for its first-in-human clinical trial of SRP-1005. SRP-1005 is an investigational siRNA therapeutic targeting Huntington's Disease, a severe neurodegenerative condition. The authorization allows Sarepta to begin a Phase 1 study, marking its clinical entry into Huntington's Disease research. Sarepta Therapeutics is best known for its Duchenne muscular dystrophy franchise, and SRP-1005 broadens its rare disease...

Core Natural Resources (CNR) has posted a mixed set of FY 2025 numbers, with Q3 revenue at about US$1.0 billion and basic EPS of US$0.61 alongside a trailing twelve month loss of US$43.4 million on basic EPS of US$0.94. The company has seen quarterly revenue move from US$553.4 million in Q3 2024 to more than US$1.0 billion in Q3 2025, while basic EPS has swung between a profit of US$3.23 and a loss of US$1.38 over that stretch. This highlights how volatile margins have been. For investors,...

If you are wondering whether Easterly Government Properties is fairly priced or offering value right now, this article will walk you through what the numbers actually say. The stock last closed at US$23.79, with a 30 day return of 6.3% and an 11.6% return year to date, set against a 3.1% decline over the past year and a 23.7% and 37.1% decline over the past 3 and 5 years respectively. Recent coverage of Easterly Government Properties has focused on its position as a real estate investment...

In February 2026, American International Group reported full-year 2025 results showing revenue of US$26.78 billion, net income of US$3.10 billion versus a prior-year net loss, declared a US$0.45 quarterly dividend, and confirmed completion of a long-running buyback program totaling about US$59.79 billion. Management also highlighted stronger underwriting income in the General Insurance segment, higher adjusted earnings, and new minority stakes in Convex Group and Onex Corporation that are...

Veralto (VLTO) is back in focus after fourth quarter revenue came in slightly below Wall Street expectations. Management pointed to fewer shipping days and softer industrial and municipal demand as key factors. See our latest analysis for Veralto. Those earnings and M&A comments landed against a weaker tape, with the latest share price at $91.98 and a 30 day share price return of 9.62% decline, adding to a 1 year total shareholder return of 7.37% decline. This suggests momentum has cooled as...

Kadant stock: event driven snapshot Kadant (KAI) has been drawing investor attention after recent share price moves, with the stock closing at $333.55. That puts the company’s market performance front and center for anyone tracking capital goods names. See our latest analysis for Kadant. That recent pullback of 0.39% on the day sits against a stronger backdrop, with a 30 day share price return of 7.03% and a 90 day gain of 30.85%. This comes even as the 1 year total shareholder return shows a...

Wendy's launched two new limited time items nationwide: the Cheesy Bacon Cheeseburger and Chicken Tenders Ranch Wrap. The releases are part of the company's Project Fresh turnaround plan, which focuses on menu changes and operations. The move comes as Wendy's closes hundreds of stores and faces pressure from declining sales. For investors watching NasdaqGS:WEN, this product push lands at a challenging point. The stock last closed at $7.27 and has seen a 47.8% decline over the past year and...

What is moving Amphastar Pharmaceuticals now? Amphastar Pharmaceuticals (AMPH) has drawn investor attention after its recent share performance, with the stock around $27.55 and short term returns mixed between the past week, month and past 3 months. See our latest analysis for Amphastar Pharmaceuticals. At around $27.55, Amphastar Pharmaceuticals has given investors a mixed ride, with recent share price returns over the past week and month soft, while the 90 day share price return of 5.72%...

If you are wondering whether ACM Research's share price still lines up with its fundamentals, this article walks through what the current valuation metrics are actually telling you. The stock last closed at US$64.10, with returns of 17.9% over 7 days, 24.9% over 30 days, 42.8% year to date, 176.3% over 1 year and 391.2% over 3 years, which naturally raises questions about how the recent price compares with estimated fair value. Recent news around ACM Research has focused on its role in...

If you are wondering whether Tencent Music Entertainment Group's current share price reflects its true worth, you are not alone. This article is built to help you make sense of the numbers. The stock closed at US$15.15, with returns of a 4.9% decline over the last 7 days, a 13.8% decline over 30 days, a 15.2% decline year to date, a 20.2% gain over 1 year, an 87.1% gain over 3 years, and a 42.3% decline over 5 years. Recent moves therefore sit within a mixed longer term picture. Recent...

The trigger for TransMedics Group (TMDX) stock today is the U.S. FDA granting full IDE approval for its Next Generation OCS ENHANCE Heart trial, a key step for advanced heart transplant procedures. See our latest analysis for TransMedics Group. Despite today’s reaction, with the share price at $128.52 after a 1-day share price return of a 3.59% decline and a softer 30-day share price return of a 9.94% decline, momentum over the past quarter remains positive and the 1-year total shareholder...

GlobalFoundries Inc. has reported its fourth-quarter and full-year 2025 results, showing flat quarterly sales of US$1,830 million year-on-year but a move from a net loss to net income, alongside new guidance for first-quarter 2026 revenue of about US$1,625 million and diluted EPS around US$0.23. The company is pairing this return to profitability with a US$500 million share repurchase program, acquisitions in silicon photonics and processor IP, and leadership changes, as it aims to deepen...

If you are wondering whether Kodiak AI at around US$8.35 is starting to look interesting on price alone, it helps to step back and look at what the current market is implying about its value. Over the short term, the stock has been under pressure, with a 7 day return of 4.4% decline, a 30 day return of 11.1% decline, and a year to date return of 22.9% decline, contributing to a 24.4% decline over the past year. This weaker share price backdrop is unfolding alongside broader evergreen...

In early February 2026, PotlatchDeltic Corporation was removed from the NASDAQ Composite Index, while multiple long-running ESOP-related shelf registrations for common stock were formally closed. This combination highlights how a technical index change, rather than routine employee stock plan administration, can have an outsized influence on trading flows and investor attention. Next, we’ll examine how PotlatchDeltic’s removal from the NASDAQ Composite Index could affect its existing...

Simon Property Group (SPG) has drawn fresh attention after unveiling a transformational plan for the former Neiman Marcus space at Boston's Copley Place, introducing new luxury retailers and high profile dining concepts. See our latest analysis for Simon Property Group. Recent news has arrived alongside mixed share price moves, with Simon Property Group's 1 day share price return of a 1.71% decline and 7 day share price return of a 2.96% decline contrasting with a 30 day share price return of...

FirstEnergy (NYSE:FE) announced a 4.5% increase to its quarterly dividend. The company also provided forward dividend guidance, outlining expectations for higher annual payouts. Management linked the dividend update to confidence in the company’s ongoing transformation and operations. For income focused investors watching utilities, this dividend move from FirstEnergy comes on top of a solid share price run. NYSE:FE is trading at $48.84, with the stock up 3.9% over the past week and 7.8%...